State-Of-The-Art Facilities and Exceptional Medical Staff
Experience Scientific Excellence and Business Experience in Preclinical Research
Research Reliable Resource for the Biomedical Community
2020 Events
COVID-ARDs – Preclinical Animal Models

ARDS, shock lung, smoke lung, Danang lung, SIRS, sepsis.
VIEW NOW

YOUR ONE STOP SHOP!
Experience quick turn around on requests and fast lead in times for your studies! Enjoy high level service and superior reporting to support your program with full preclinical and histopathology services.
Contact Us
Latest News
January, 2021
CAROTID ARTERY STUDIES
Read more
January, 2021
Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
Read more
December, 2020
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
Read more
December, 2020
ONCOLYTIC VIRAL VACCINE STUDIES Read more
November, 2020
OTOTOXICITY STUDIES Read more
October, 2020
TISSUE CROSS-REACTIVITY STUDIES Read more
September, 2020
BLADDER CANCER STUDIES AT CBI. Read more
August, 2020
CBI JOINES GENESIS – FROM Dr. CAROL MESCHTER Read more
August, 2020
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
Read more
August, 2020
IMIQUIMOD-INDUCED PSORIASIS Read more
July, 2020
ANIMALS AND COVID-19 RESEARCH AT CBI
Read more
June, 2020
OPEN FOR BUSINESS AT CBI
Read more
May, 2020
BUSINESS AS USUAL AROUND HERE
Read more
April, 2020
FROM THE DESK OF DR. CAROL MESCHTER
Read more
March, 2020
CONTINUING OUR SERVICES TO THE HIGHEST LEVELS AT CBI
Read more
February, 2020
CORONAVIRUS TREATMENT STUDIES AT CBI
Read more
January, 2020
ONCOLYTIC VIRAL VACCINE AT CBI
Read more
January, 2019
Intraocular Lens Implantation Studies
Read more
November, 2018
Pompe Disease Studies
Read more
October, 2018
Fibrosis Inflammation
Read more
September, 2018
Skin Closure Published Article 2018
Read more
August, 2018
Pulmonary Studies
Read more
July, 2018
Wound Healing Studies
Read more
June, 2018
Central Nervous System Studies
Read more
May, 2018
Success at ARVO 2018 – Honolulu, Hawaii
Read more
April 29 – May 3, 2018
Visit CBI at ARVO 2018 – Annual Meeting
Read more
March, 2018
Burns and Dermatitis Studies
Read more
February, 2018
Visit CBI at SOT 2018 – Annual Meeting and Tox Expo
Read more
January, 2018
CBI Congratulates Meridigen Biotech Co. on a Successful IND Project
Read more
Stay up to date with the latest CBI and industry news.
Comparative Biosciences, Inc. (CBI) offers preclinical toxicology and pharmacokinetics services, and efficacy studies to all sectors of the biomedical and biopharmaceutical communities, with specialized expertise in dermatology, ophthalmology, oncology, wound healing, inflammation and cardiovascular and infectious disease. CBI is AAALAC accredited and registered with the FDA, USDA and OLAW.